SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending on heightened anticipation of a significant NASA Lunar Terrain Vehicle contract award, further fueled by an analyst upgrade and a broader focus on American space superiority. Community discussion centers on the potential for a short squeeze and a substantial rally in the space sector, with many speculating on the timing and impact of impending contract news.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth is trending amidst heightened political rhetoric surrounding healthcare costs and the debate over extending Affordable Care Act subsidies, creating significant investor uncertainty. The community is sharply divided, with some anticipating negative market impacts from potential government interventions, while others view current price movements as buying opportunities, citing the company's robust fundamentals and defensive sector positioning.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to a significant $805 million Space Development Agency contract win, which firmly establishes its position alongside major defense primes for critical missile-tracking satellite programs. Community discussion is highly bullish, emphasizing this contract as a pivotal validation and anticipating further catalysts from the Neutron rocket and a potential re-rating of the broader space sector.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following its selection for the U.S. Department of Energy's Genesis Mission, a development largely seen as significant validation for its AI infrastructure. This news is fueling an intense rally and sparking community discussions about a potential short squeeze, with many traders anticipating sustained upward momentum. While sentiment is predominantly bullish, some participants are expressing caution about the rapid ascent and potential profit-taking.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is drawing significant attention following recent positive developments, including key government contract inclusions and a Bank of America price target update, reinforcing its position as a leading AI software provider. The community remains sharply divided, with bulls emphasizing its essential role in AI and defense, while bears warn of an unsustainable valuation and potential for a sharp correction. This ongoing debate underscores its highly speculative nature and strong retail interest.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is experiencing a surge in community attention and trending due to intense speculation surrounding its exceptionally low public float, fueling discussions of a potential short squeeze. Traders are closely watching its volatile price action and comparing its breakout potential to other past runners, while the broader context includes its Nasdaq listing and reported holding of Solana. The community is actively discussing breaking key resistance levels amidst unusual trading halts, anticipating significant upside.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is garnering significant attention following recent contracts, including an eight-figure deal for spacecraft docking systems and a substantial DARPA award for an air-breathing spacecraft, solidifying its position in advanced space infrastructure. The community is actively discussing the company's long-term prospects in space-based data centers and other ambitious projects, widely considering it an undervalued player with immense potential within the rapidly expanding aerospace and defense sectors.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending significantly lower following its recent earnings report, despite surpassing revenue and EPS estimates, driven by market apprehension over declining profits, margin compression, and continued weakness in Greater China sales. The community is sharply divided, with some investors seeing a prime buying opportunity in the consumer giant, while others express deep concern over increasing competition and management's strategy amid a challenging global market.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as it officially launches its Prediction Market app, a strategic move expanding its addressable market to several states without traditional sports betting and directly addressing competition in the evolving prediction space. This launch has generated mixed reactions within the community, with some viewing it as a critical growth opportunity while others express frustration over the stock's subdued immediate price action despite the significant development.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid excitement over a strategic partnership with C Speed for AI-powered border security and the integration of Ask Sage's CEO as its new CTO, significantly bolstering its defense AI capabilities. The community is keenly anticipating substantial government contracts, particularly with TSA, and discussing an upcoming share authorization vote, with many believing smart money is accumulating shares ahead of expected long-term growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Frazier Life Sciences Management L.P. Has $17.79 Million Position in Lexeo Therapeutics, Inc. $LXEO

Frazier Life Sciences Management L.P. lifted its holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Free Report) by 363.1% in the 2nd quarter, according to the company in its most recent disclosure...

Lexeo Therapeutics' (LXEO) Buy Rating Reaffirmed at Chardan Capital

Chardan Capital reaffirmed a "buy" rating and issued a $17.00 price objective on shares of Lexeo Therapeutics in a research report on Thursday...

Lexeo Therapeutics (NASDAQ:LXEO) Trading Down 7.8% - What's Next?

Lexeo Therapeutics (NASDAQ:LXEO) Shares Down 7.8% - Here's What Happened...

Lexeo Therapeutics (NASDAQ:LXEO) Now Covered by Analysts at Cantor Fitzgerald

Cantor Fitzgerald initiated coverage on shares of Lexeo Therapeutics in a research note on Monday. They set an "overweight" rating and a $19.00 target price for the company...

Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 1,127 Shares of Stock

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Nolan Townsend sold 1,127 shares of the company's stock in a transaction that occurred on Tuesday, November 18th. The stock was...

Lexeo Therapeutics (NASDAQ:LXEO) Coverage Initiated at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Lexeo Therapeutics in a research report on Thursday. They set an "overweight" rating and a $19.00 price target for the company...

Equities Analysts Set Expectations for LXEO FY2025 Earnings

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Free Report) - Equities researchers at HC Wainwright raised their FY2025 earnings per share estimates for Lexeo Therapeutics in a note issued to investors on...

Wall Street Analysts Predict a 124.3% Upside in Lexeo Therapeutics, Inc. (LXEO): Here's  What You Should Know

The consensus price target hints at a 124.3% upside potential for Lexeo Therapeutics, Inc. (LXEO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Research Analysts Set Expectations for LXEO FY2025 Earnings

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for shares of Lexeo Therapeutics in a report...

Lexeo Therapeutics (NASDAQ:LXEO) Announces Earnings Results

Lexeo Therapeutics (NASDAQ:LXEO - Get Free Report) released its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, topping analysts' consensus estimates of ($0.48) by...

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

Current Price	$10.51
Prev Close	$9.96
Open	$10.10
Dividend Yield	0.00%
50-Day Moving Average	$9.18
Beta	1.95
Avg. Volume	1.39M
PE Ratio	-3.69

52-Week High	$10.56
52-Week Low	$1.45
Market Capitalization	$727.23M
EPS (Annual)	-$3.09
Price to Book	4.53
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

LXEO
Lexeo Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LXEO News

LXEOLexeo Therapeutics Inc.